COVID patients left with few treatment options after antibodies found ineffective against omicron

Retrieved on: 2022-01-26 22:54:15

Tags for this article:

Life Sciences

Medical specialties

Health sciences

Monoclonal antibodies

COVID-19 drug development

Antiviral drugs

Occupational safety and health

Regeneron Pharmaceuticals

SARS-CoV-2 Omicron variant

Sotrovimab

COVID-19

Food and Drug Administration

Regeneron

Click the tags to see associated articles and topics

COVID patients left with few treatment options after antibodies found ineffective against omicron. View article details on HISWAI: https://www.fox13news.com/news/covid-patients-left-with-few-treatment-options-after-antibodies-found-ineffective-against-omicron

Excerpt

With the most common monoclonal antibody treatments off the table and new antiviral drugs in short supply, people with COVID-19 have few options ...

Article found on: www.fox13news.com

View Original Article